WallStreetZenWallStreetZen

NASDAQ: XLO
Xilio Therapeutics Inc Stock Ownership - Who owns Xilio Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Xilio Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James Samuel ShannonDirector2026-03-265,000$8.79
$43.95kBuy
Kevin M. BrennanSVP FINANCE AND ACCOUNTING2026-01-021,826$0.64
$1.17kSell
Christopher James FrankenfieldChief Financial Officer2026-01-027,030$0.64
$4.52kSell

1 of 1

XLO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when XLO insiders and whales buy or sell their stock.

XLO Shareholders

What type of owners hold Xilio Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Gilead Sciences Inc138.38%9,105,451$81.31MInsider
Yekaterina Chudnovsky106.38%7,000,000$62.51MInsider
Sv7 Impact Medicine Fund LP49.05%3,227,264$28.82MInsider
Bain Capital Life Sciences Investors LLC42.63%2,805,413$25.05MInsider
Atlas Venture Fund XI LP41.85%2,754,109$24.59MInsider
James E. Flynn34.77%2,287,944$20.43MInsider
Takeda Pharmaceutical Co Ltd22.42%1,475,121$13.17MInsider
Rivervest Venture Fund IV LP21.91%1,441,444$12.87MInsider
Rock Springs Capital Management LP19.09%1,256,472$11.22MInsider
Bay City Capital LLC17.17%1,129,490$10.09MInsider

1 of 3

XLO vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
XLO0.01%99.99%Net Selling
EXOZ0.00%100.00%Net BuyingNet Buying
IMA0.05%97.30%Net BuyingNet Selling
HRTX0.07%66.04%Net SellingNet Selling
FRMM0.02%99.98%Net SellingNet Selling
View Top Biotech Stocks

Xilio Therapeutics Stock Ownership FAQ

Who owns Xilio Therapeutics?

Xilio Therapeutics (NASDAQ: XLO) is owned by 0.05% institutional shareholders, 528.70% Xilio Therapeutics insiders, and 0.00% retail investors. Gilead Sciences Inc is the largest individual Xilio Therapeutics shareholder, owning 9.11M shares representing 138.38% of the company. Gilead Sciences Inc's Xilio Therapeutics shares are currently valued at $81.31M.

If you're new to stock investing, here's how to buy Xilio Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.